Clinical Trial Update: A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating DCR-PHXC in children and adults with Primary Hyperoxaluria Type 1 and Type 2 has completed, with results posted on May 22, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria Type

Drugs mentioned

• DCR-PHXC

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2) | Phase 2 | Status: COMPLETED | Results posted: 2024-05-22